Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…
Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…
Although the pandemic is considered over, this is not expected to immediately reduce sales of OTC cough and cold medicines in Indonesia in 2023, with both retail volume and current value growth set to continue across most categories. However, the…
Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…
As COVID-19 restrictions lift and society returns to face-to-face interaction, the regular seasonal sicknesses —colds and flus—are making their own return to Azerbaijan. More social mingling means not just handshakes and hugs on the rise; sniffling…
As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…
Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…
Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…
Cough, cold and allergy (hay fever) remedies witnessed an improved performance in constant value terms in 2023. This was due, in a large part, to a return of pre-pandemic lifestyles, including the reopening of schools and workspaces, which…
Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…